Skip to main content
. 2019 Feb 5;40(8):2413–2421. doi: 10.1002/hbm.24532

Table 1.

Demographic and behavioral data

GHB‐Coma (N = 23) GHB‐NoComa (N = 22) No‐GHB (N = 24) Difference
Mean ±SD Mean ±SD Mean ±SD p
Age 25.52 5.62 25.86 4.44 28.04 9.41 0.402a
Educational level 6.57 1.67 6.91 1.11 6.63 1.28 0.672a
Premorbid IQ 89.86 10.65 98.44 7.89 93.41 8.08 0.008a , b
Years since first use 5.70 3.94 4.45 2.11 0.575c
Daily dose (mL/day) 46.77 39.19 19.69 11.36 <0.001c
Days of GHB‐use in preceding 30 days 11.48 12.74 2.77 2.27 0.085c
Months of daily use 25.28 45.03 0.14 0.42 0.008c
Frame‐wise displacement 0.10 0.05 0.08 0.02 0.09 0.02 0.170a

Abbreviations: SD = standard deviation.

a

Analysis of variance (ANOVA).

b

Post hoc Tukey HSD: premorbid IQ_GHB‐Coma<GHB‐NoComa p = 0.006.

c

Mann–Whitney U.